Zonal heterogeneity of peroxisome proliferation in rat liver. 1996

H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
Department of Anatomy and Cell Biology, University of Heidelberg, Germany.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002451 Cell Compartmentation A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc. Cell Compartmentations,Compartmentation, Cell,Compartmentations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015262 Xenobiotics Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc. Xenobiotic
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic

Related Publications

H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
December 1989, Journal of lipid research,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
April 1989, Hepatology (Baltimore, Md.),
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
January 1992, Enzyme,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
January 1992, Pathobiology : journal of immunopathology, molecular and cellular biology,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
August 1977, Biochemical and biophysical research communications,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
March 1986, Cancer research,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
August 1972, The Biochemical journal,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
June 1995, The American journal of physiology,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
January 1990, The International journal of biochemistry,
H D Fahimi, and K Beier, and M Lindauer, and A Schad, and J Zhan, and J Pill, and W Rebel, and A Völkl, and E Baumgart
April 1989, Gastroenterology,
Copied contents to your clipboard!